These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 22236804

  • 1. Effects of adding omalizumab, an anti-immunoglobulin E antibody, on airway wall thickening in asthma.
    Hoshino M, Ohtawa J.
    Respiration; 2012; 83(6):520-8. PubMed ID: 22236804
    [Abstract] [Full Text] [Related]

  • 2. Effects of budesonide/formoterol combination therapy versus budesonide alone on airway dimensions in asthma.
    Hoshino M, Ohtawa J.
    Respirology; 2012 May; 17(4):639-46. PubMed ID: 22248352
    [Abstract] [Full Text] [Related]

  • 3. Effect of omalizumab as add-on therapy on asthma-related quality of life in severe allergic asthma: a Brazilian study (QUALITX).
    Rubin AS, Souza-Machado A, Andradre-Lima M, Ferreira F, Honda A, Matozo TM, QUALITX Study Investigators.
    J Asthma; 2012 Apr; 49(3):288-93. PubMed ID: 22356355
    [Abstract] [Full Text] [Related]

  • 4. Airway wall thickness in asthma assessed by computed tomography. Relation to clinical indices.
    Niimi A, Matsumoto H, Amitani R, Nakano Y, Mishima M, Minakuchi M, Nishimura K, Itoh H, Izumi T.
    Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1518-23. PubMed ID: 11029371
    [Abstract] [Full Text] [Related]

  • 5. Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma.
    Djukanović R, Wilson SJ, Kraft M, Jarjour NN, Steel M, Chung KF, Bao W, Fowler-Taylor A, Matthews J, Busse WW, Holgate ST, Fahy JV.
    Am J Respir Crit Care Med; 2004 Sep 15; 170(6):583-93. PubMed ID: 15172898
    [Abstract] [Full Text] [Related]

  • 6. Relationship of airway wall thickening to an imbalance between matrix metalloproteinase-9 and its inhibitor in asthma.
    Matsumoto H, Niimi A, Takemura M, Ueda T, Minakuchi M, Tabuena R, Chin K, Mio T, Ito Y, Muro S, Hirai T, Morita S, Fukuhara S, Mishima M.
    Thorax; 2005 Apr 15; 60(4):277-81. PubMed ID: 15790981
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: an open-label study.
    Niven R, Chung KF, Panahloo Z, Blogg M, Ayre G.
    Respir Med; 2008 Oct 15; 102(10):1371-8. PubMed ID: 18657960
    [Abstract] [Full Text] [Related]

  • 8. Comprehensive efficacy of omalizumab for severe refractory asthma: a time-series observational study.
    Tajiri T, Niimi A, Matsumoto H, Ito I, Oguma T, Otsuka K, Takeda T, Nakaji H, Inoue H, Iwata T, Nagasaki T, Kanemitsu Y, Izuhara Y, Mishima M.
    Ann Allergy Asthma Immunol; 2014 Oct 15; 113(4):470-5.e2. PubMed ID: 24994694
    [Abstract] [Full Text] [Related]

  • 9. Effectiveness of omalizumab in a patient with severe asthma, low serum IgE level, and lack of sensitized allergens induced by oral steroid therapy: the usefulness of impulse oscillation for assessment of omalizumab therapy.
    Matsuno O, Komori C, Hang Y, Matsumoto T, Minamoto S.
    J Asthma; 2012 Oct 15; 49(8):839-42. PubMed ID: 22920591
    [Abstract] [Full Text] [Related]

  • 10. A 36-month study on the cost/utility of add-on omalizumab in persistent difficult-to-treat atopic asthma in Italy.
    Dal Negro RW, Tognella S, Pradelli L.
    J Asthma; 2012 Oct 15; 49(8):843-8. PubMed ID: 22954018
    [Abstract] [Full Text] [Related]

  • 11. A 26-week, randomized, double-blind, placebo-controlled, multicenter study to evaluate the effect of omalizumab on asthma control in patients with persistent allergic asthma.
    Bardelas J, Figliomeni M, Kianifard F, Meng X.
    J Asthma; 2012 Mar 15; 49(2):144-52. PubMed ID: 22277052
    [Abstract] [Full Text] [Related]

  • 12. Omalizumab protects against allergen- induced bronchoconstriction in allergic (immunoglobulin E-mediated) asthma.
    Zielen S, Lieb A, De La Motte S, Wagner F, de Monchy J, Fuhr R, Munzu C, Koehne-Voss S, Rivière GJ, Kaiser G, Erpenbeck VJ.
    Int Arch Allergy Immunol; 2013 Mar 15; 160(1):102-10. PubMed ID: 22948442
    [Abstract] [Full Text] [Related]

  • 13. Omalizumab attenuates airway inflammation and interleukin-5 production by mononuclear cells in patients with severe allergic asthma.
    Takaku Y, Soma T, Nishihara F, Nakagome K, Kobayashi T, Hagiwara K, Kanazawa M, Nagata M.
    Int Arch Allergy Immunol; 2013 Mar 15; 161 Suppl 2():107-17. PubMed ID: 23711861
    [Abstract] [Full Text] [Related]

  • 14. Relationship of airway wall thickness to airway sensitivity and airway reactivity in asthma.
    Niimi A, Matsumoto H, Takemura M, Ueda T, Chin K, Mishima M.
    Am J Respir Crit Care Med; 2003 Oct 15; 168(8):983-8. PubMed ID: 12829452
    [Abstract] [Full Text] [Related]

  • 15. Effect of treatment with inhaled corticosteroid on serum periostin levels in asthma.
    Hoshino M, Ohtawa J, Akitsu K.
    Respirology; 2016 Feb 15; 21(2):297-303. PubMed ID: 26607392
    [Abstract] [Full Text] [Related]

  • 16. RANTES in exhaled breath condensate of patients with severe persistent allergic asthma during omalizumab therapy.
    Zietkowski Z, Skiepko R, Tomasiak-Lozowska MM, Lenczewska D, Bodzenta-Lukaszyk A.
    Int Arch Allergy Immunol; 2011 Feb 15; 154(1):25-32. PubMed ID: 20664274
    [Abstract] [Full Text] [Related]

  • 17. [Omalizumab treatment in patients with asthma: summary of Meir Medical Center experience with 47 patients].
    Shitrit D, Talker O, Metabichek A, Yaakovi I.
    Harefuah; 2012 Apr 15; 151(4):216-9, 254, 253. PubMed ID: 22616149
    [Abstract] [Full Text] [Related]

  • 18. Assessment of long-term omalizumab treatment in patients with severe allergic asthma long-term omalizumab treatment in severe asthma.
    Özgür ES, Özge C, Ïlvan A, Naycı SA.
    J Asthma; 2013 Aug 15; 50(6):687-94. PubMed ID: 23557459
    [Abstract] [Full Text] [Related]

  • 19. Omalizumab modulates bronchial reticular basement membrane thickness and eosinophil infiltration in severe persistent allergic asthma patients.
    Riccio AM, Dal Negro RW, Micheletto C, De Ferrari L, Folli C, Chiappori A, Canonica GW.
    Int J Immunopathol Pharmacol; 2012 Aug 15; 25(2):475-84. PubMed ID: 22697079
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with poorly controlled (moderate-to-severe) allergic asthma.
    Ayres JG, Higgins B, Chilvers ER, Ayre G, Blogg M, Fox H.
    Allergy; 2004 Jul 15; 59(7):701-8. PubMed ID: 15180756
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.